Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v4-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-04-13 | 2022-04-13 |
| Drug Identification Number | 02392453 | 02392453 |
| Brand name | HEPARIN SODIUM INJECTION, USP | HEPARIN SODIUM INJECTION, USP |
| Common or Proper name | Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL | Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
| Strength(s) | 10000UNIT | 10000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 0.5mL | 0.5mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-02-01 | 2022-02-01 |
| Estimated end date | 2022-04-18 | 2022-04-18 |
| Actual end date | 2022-04-04 | 2022-04-04 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, our Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL allocations will be reduced to 50% effective February 1, 2022 and will be on backorder effective March 1, 2022 until April 18, 2022. | Fresenius Kabi Canada regrets to advise that due to a production delay, our Heparin Sodium Injection, USP 10,000USP units/mL SD Vial 0.5mL allocations will be reduced to 50% effective February 1, 2022 and will be on backorder effective March 1, 2022 until April 18, 2022. |
| Health Canada comments |